arrow
T

Tina Duong

Stanford University
H指数:38
被引数:5,782

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

New SMA era: A broad-range tiered assessment of function for the evolving SMA phenotype (EVOLVE-SMA)

新SMA时代:针对不断演变的SMA表型的广谱分级功能评估(EVOLVE-SMA)

2025-12-300
PRE
Heart Transplantation and Ventricular Assist Device in Duchenne Muscular Dystrophy: A New Era

心脏移植与心室辅助装置在杜氏肌营养不良症中的应用:一个新时代

2025-12-210
PRE
Consensus recommendations and considerations for the delivery and monitoring of gene therapy in patients with Duchenne muscular dystrophy

关于在杜氏肌营养不良症患者中实施基因治疗及监测的共识推荐与考量

2025-08-230
PRE
Serial casting for contractures in SMA: consensus derived guidelines for treatment

脊髓性肌萎缩症(SMA)挛缩的系列石膏固定:治疗共识指南

2025-04-160
OA
Cardiopulmonary exercise testing as an integrative approach to explore physiological limitations in Duchenne muscular dystrophy

心肺运动试验作为一种整合性方法,用于探索杜氏肌营养不良症中的生理限制。

2025-03-040
PRE
JEWELFISH: 24-month results from an open-label study in non-treatment-naïve patients with SMA receiving treatment with risdiplam

Chiriboga, C.A.; Bruno, C.; Duong, T.; Fischer, D.; Mercuri, E.; Kirschner, J.; Kostera-Pruszczyk, A.; Jaber, B.; Ksenija, G.; Heidemarie, K.; 等. JEWELFISH:一项开放标签研究中接受Risdiplam治疗的非初治型脊髓性肌萎缩症患者的24个月结果。J. Neurol. 2024, 271, 4871–4884. [Google Scholar] [CrossRef]

2024-05-110
OAAI
Safety and Efficacy of Apitegromab in Patients With Spinal Muscular Atrophy Types 2 and 3

Apitegromab在2型和3型脊髓性肌萎缩症患者中的安全性和有效性

2024-03-126
OAAI
Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3

未经治疗的2型和3型脊髓性肌萎缩症患者队列中修订的Hammersmith量表中的疾病轨迹

2024-02-275
OAAI
Assessing the Assisted Six-Minute Cycling Test as a Measure of Endurance in Non-Ambulatory Patients with Spinal Muscular Atrophy (SMA)

评估辅助的六分钟循环测试,以衡量非卧床患者的耐力脊髓性肌萎缩症 (SMA)

2023-12-081
OAAI
Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study (vol 12, pg 543, 2023)
2023-07-030
OAAI
2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA Participants

未经治疗的儿科2型和3型SMA参与者的大型队列中修订的Hammersmith量表评分的2年变化

2023-02-287
OAAI